Skip to main content

NCT00082602 - Galantamine ER Open Label Rapid Dose Escalation Trial in Alzheimer's Disease

Galantamine ER Open Label Rapid Dose Escalation Trial in Alzheimer's Disease

Data Request Dashboard


No data requests found. Click here to generate a new one.

CSR Summary

Not Yet Available

Data Specification

Not Available

Annotated CRF

Not Available

Product Info

Generic Name
Galantamine hydrobromide
Product Name
Therapeutic Area
Behaviors and Mental Disorders
% Female
% White
Product Class
Alzheimer's Disease - Cholinesterase Inhibitors
Sponsor Protocol Number
Data Holder
Johnson & Johnson
Condition Studied
Alzheimer Disease
Mean/Median Age (Years)

Supporting Documentation

Data Definition Specification Available
Annotated Case Report Form Available
Clinical Study Report
Protocol with Amendments
Statistical Analysis Plan
Study Phase 
Additional Information: 

Please note: individual participant-level data are not available for this trial. Only the protocol, statistical analysis plan, and full clinical study report are available.


Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.